RxDoctor Payments Data

Eric Carlon, APRN

Psychiatric/Mental Health · Sanford, FLNPI 1013525294

Payments from drug & device makers

$2,388in general payments, 2019–2025

Across 40 payments — averaging $59.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$1K
  • Teva Pharmaceuticals USA, Inc.$591
  • Neurocrine Biosciences, Inc.$180
  • Alpha Cognition USA, Inc.$144
  • Alkermes, Inc.$98
  • Otsuka America Pharmaceutical, Inc.$68
  • plus $124 from 5 others

What the payments were for

  • Consulting fees$1,17549%
  • Food & beverage$1,13347%
  • Education$803%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,388 in reported general payments places this provider in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$333,386
Medicare patients
391
Services billed
3,609

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine43$339,216
Invega SustennaPaliperidone Palmitate13$46,173
TrintellixVortioxetine Hydrobromide30$14,730
BelsomraSuvorexant28$10,738
Mirtazapine202$5,712
Olanzapine OdtOlanzapine27$4,639
EliquisApixaban14$4,607
Quetiapine Fumarate340$4,596
Paroxetine Hcl168$3,703
Buspirone Hcl357$3,589
Olanzapine81$3,092
Trazodone Hcl280$2,820
Risperidone199$2,703
Clozapine17$2,618
Lorazepam248$2,155

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$591$339,21643 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Sanford

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →